インデックス付き
- Jゲートを開く
- Genamics JournalSeek
- サイテファクター
- コスモスIF
- シマゴ
- ウルリッヒの定期刊行物ディレクトリ
- 電子ジャーナルライブラリ
- レフシーク
- ハムダード大学
- エブスコ アリゾナ州
- 雑誌の抄録索引作成ディレクトリ
- OCLC-WorldCat
- プロクエスト召喚
- 学者の舵取り
- 道
- 仮想生物学図書館 (vifabio)
- パブロン
- ジュネーブ医学教育研究財団
- Google スカラー
このページをシェアする
ジャーナルチラシ
概要
Evaluation of Angiogenic Potential of 1-Monocaproin Using Chick Chorioallantoic Membrane Assay
Palaniappan Maheswari and Kasthuri Revathi
1-Monocaproin, a 1-monoacylglycerol, was synthesized with the reaction of glycidol by chromium-caproic fatty acid complexes and was found to be amphiphilic in nature. Synthesized 1-monocaproin was characterized by thin-layer chromatography, and the residual chromium was analyzed using inductively coupled plasma mass spectroscopy. Vascular endothelium growth factor (VEGF)-mediated angiogenesis pathways are being targeted for the development of novel drugs suitable for inhibition or stimulation of angiogenesis in various pathologies. In the chicken egg Chorioallantoic membrane (CAM) assay, 1-monocaproin exhibited VEGF-induced neovascularization in a dose-dependent manner. Synthesized 1-monocaproin was found to show the angiogenic effect at a dose concentration equivalent to VEGF at 1,000 ppm. The results thus suggest that 1-monocaproin should be considered as a useful drug candidature targeting angiogenesis in coronary artery disease, stroke, and postsurgical therapy.